Leading the way to safer medication
 Crosscheck  Recommender

DHC CONTINUS Prolonged release tablet (2020)

Product Name and Form

DHC CONTINUS 60 mg, 90 mg and 120 mg prolonged release tablets.

Pharmaceutical form

Prolonged release tablet.

White capsule-shaped tablet. 60 mg tablets are marked DHC 60, 90 mg tablets are marked DHC 90 and 120 mg tablets are marked DHC 120.

Qualitative and Quantitative Composition

Each 60 mg tablet contains dihydrocodeine tartrate 60 mg.

Each 90 mg tablet contains dihydrocodeine tartrate 90 mg.

Each 120 mg tablet contains dihydrocodeine tartrate 120 mg.

Excipient with known effect:

Each 60 mg tablet contains lactose anhydrous 58.4 mg.

Each 90 mg tablet contains lactose anhydrous 40.5 mg.

Each 120 mg tablet contains lactose anhydrous 54 mg.

For the full list of excipients, see section 6.1.

List of excipients

Lactose (anhydrous)
Hydroxyethylcellulose
Cetostearyl Alcohol
Magnesium Stearate
Purified Talc
Purified Water

Pack sizes and Marketing

  1. 20μm hard tempered aluminium foil backed PVdC/PVC blister packs (8 or 56 tablets).
  2. Polypropylene containers with polyethylene lids (8, 56 or 250 tablets).
  3. Polyethylene containers with polypropylene lids (56 tablets).
Marketing authorization holder
Authorization dates

Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge, CB4 0GW

01 September 1999

Marketing authorization number:

PL 16950/0019
PL 16950/0020
PL 16950/0021